What is it about?
Patients who have organ transplants are immunosuppressed from the medications needed to prevent rejection of the transplnted organ. These medications can increase the risk of infections or malignancies. Due to these risks choosing a treatment for psoriasis can be difficult.
Featured Image
Why is it important?
As there is very little information on treating psoriasis in patients with organ transplants, we give guidelines based on expert opinions from the National Psoriasis Foundation Medical Board.
Perspectives
This was a needed paper to help guide treatment in patients with psoriasis who also have solid organ transplants. The goal is to treat psoriasis while minimizing the risks from the immunosuppressive medications needed to prevent rejection of solid organ transplants.
Ronald Prussick
George Washington University
Read the Original
This page is a summary of: Psoriasis in solid organ transplant patients: best practice recommendations from The Medical Board of the National Psoriasis Foundation, Journal of Dermatological Treatment, October 2017, Taylor & Francis,
DOI: 10.1080/09546634.2017.1373737.
You can read the full text:
Contributors
The following have contributed to this page
